Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification.

Disease-specific induced pluripotent stem cells. Cell (2008) 16.95

Detection of specific polymerase chain reaction product by utilizing the 5'----3' exonuclease activity of Thermus aquaticus DNA polymerase. Proc Natl Acad Sci U S A (1991) 16.94

Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (2002) 15.11

Short-sequence DNA repeats in prokaryotic genomes. Microbiol Mol Biol Rev (1998) 8.47

Genetic analysis of amplified DNA with immobilized sequence-specific oligonucleotide probes. Proc Natl Acad Sci U S A (1989) 7.79

Real-time PCR in virology. Nucleic Acids Res (2002) 6.71

DNA typing and genetic mapping with trimeric and tetrameric tandem repeats. Am J Hum Genet (1991) 6.20

Prevention of pre-PCR mis-priming and primer dimerization improves low-copy-number amplifications. Nucleic Acids Res (1992) 5.98

Five polymorphic microsatellite VNTRs on the human X chromosome. Am J Hum Genet (1990) 5.38

The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion. Am J Hum Genet (1989) 5.09

Genetic disease detection and DNA amplification using cloned thermostable ligase. Proc Natl Acad Sci U S A (1991) 4.89

Multiplex PCR: optimization and application in diagnostic virology. Clin Microbiol Rev (2000) 4.33

Multigene amplification and massively parallel sequencing for cancer mutation discovery. Proc Natl Acad Sci U S A (2007) 3.93

Topography of the Duchenne muscular dystrophy (DMD) gene: FIGE and cDNA analysis of 194 cases reveals 115 deletions and 13 duplications. Am J Hum Genet (1989) 3.81

Multiplex PCR for typing and subtyping influenza and respiratory syncytial viruses. J Clin Microbiol (1998) 3.78

Exploring the molecular basis for variability among patients with Becker muscular dystrophy: dystrophin gene and protein studies. Am J Hum Genet (1991) 2.79

Measurement of locus copy number by hybridisation with amplifiable probes. Nucleic Acids Res (2000) 2.70

Multiplex amplification of all coding sequences within 10 cancer genes by Gene-Collector. Nucleic Acids Res (2007) 2.70

Detection of specific DNA sequences by fluorescence amplification: a color complementation assay. Proc Natl Acad Sci U S A (1989) 2.67

Multiplex reverse transcription-PCR for surveillance of influenza A and B viruses in England and Wales in 1995 and 1996. J Clin Microbiol (1997) 2.45

Molecular diagnosis of herpes simplex virus infections in the central nervous system. J Clin Microbiol (1999) 2.21

Rapid detection of CA polymorphisms in cloned DNA: application to the 5' region of the dystrophin gene. Am J Hum Genet (1991) 2.17

The elimination of primer-dimer accumulation in PCR. Nucleic Acids Res (1997) 2.15

Molecular and phenotypic analysis of patients with deletions within the deletion-rich region of the Duchenne muscular dystrophy (DMD) gene. Am J Hum Genet (1989) 2.12

Adeno-associated virus-mediated microdystrophin expression protects young mdx muscle from contraction-induced injury. Mol Ther (2005) 2.08

Fragile X syndrome: diagnosis using highly polymorphic microsatellite markers. Am J Hum Genet (1991) 1.95

Carrier detection and prenatal diagnosis in Duchenne and Becker muscular dystrophy families, using dinucleotide repeat polymorphisms. Am J Hum Genet (1991) 1.93

Insertion of a 5' truncated L1 element into the 3' end of exon 44 of the dystrophin gene resulted in skipping of the exon during splicing in a case of Duchenne muscular dystrophy. J Clin Invest (1993) 1.92

Fragile-X syndrome: unique genetics of the heritable unstable element. Am J Hum Genet (1992) 1.85

Experience and strategy for the molecular testing of Duchenne muscular dystrophy. J Mol Diagn (2005) 1.82

miRNAs as serum biomarkers for Duchenne muscular dystrophy. EMBO Mol Med (2011) 1.80

Happy mapping: linkage mapping using a physical analogue of meiosis. Nucleic Acids Res (1993) 1.77

Polymerase chain reaction based assay to detect allelic loss in human DNA: loss of beta-interferon gene in chronic myelogenous leukemia. Nucleic Acids Res (1990) 1.76

Mutations in p53 as potential molecular markers for human breast cancer. Proc Natl Acad Sci U S A (1991) 1.65

Touchdown enzyme time release-PCR for detection and identification of Chlamydia trachomatis, C. pneumoniae, and C. psittaci using the 16S and 16S-23S spacer rRNA genes. J Clin Microbiol (2000) 1.60

Accurate diagnosis of carriers of deletions and duplications in Duchenne/Becker muscular dystrophy by fluorescent dosage analysis. J Med Genet (1996) 1.55

Comprehensive detection of genomic duplications and deletions in the DMD gene, by use of multiplex amplifiable probe hybridization. Am J Hum Genet (2002) 1.55

Multiplex allele-specific target amplification based on PCR suppression. Proc Natl Acad Sci U S A (2001) 1.54

Dystrophin analysis using a panel of anti-dystrophin antibodies in Duchenne and Becker muscular dystrophy. J Neurol Neurosurg Psychiatry (1993) 1.49

2004 William Allan Award address. Cloning of the DMD gene. Am J Hum Genet (2005) 1.45

Multiplex PCR: use of heat-stable Thermus thermophilus RecA protein to minimize non-specific PCR products. Nucleic Acids Res (2005) 1.43

High-density multiplex detection of nucleic acid sequences: oligonucleotide ligation assay and sequence-coded separation. Nucleic Acids Res (1994) 1.41

Detection of novel genetic markers by mismatch analysis. Nucleic Acids Res (1989) 1.36

Use of epitope libraries to identify exon-specific monoclonal antibodies for characterization of altered dystrophins in muscular dystrophy. Am J Hum Genet (1993) 1.33

MLPA analysis for the detection of deletions, duplications and complex rearrangements in the dystrophin gene: potential and pitfalls. Neurogenetics (2005) 1.32

Detection of mutations in the dystrophin gene via automated DHPLC screening and direct sequencing. BMC Genet (2001) 1.31

Homogeneous multiplex genotyping of hemochromatosis mutations with fluorescent hybridization probes. Am J Pathol (1998) 1.30

A convenient multiplex PCR system for the detection of dystrophin gene deletions: a comparative analysis with cDNA hybridisation shows mistypings by both methods. J Med Genet (1991) 1.23

Frameshift deletions of exons 3-7 and revertant fibers in Duchenne muscular dystrophy: mechanisms of dystrophin production. Am J Hum Genet (1995) 1.23

Use of the MLPA assay in the molecular diagnosis of gene copy number alterations in human genetic diseases. Int J Mol Sci (2012) 1.21

Multiplex asymmetric PCR-based oligonucleotide microarray for detection of drug resistance genes containing single mutations in Enterobacteriaceae. Antimicrob Agents Chemother (2007) 1.19

Human and murine dystrophin mRNA transcripts are differentially expressed during skeletal muscle, heart, and brain development. Nucleic Acids Res (1992) 1.19

Detection of human immunodeficiency virus type 1 by using the polymerase chain reaction and a time-resolved fluorescence-based hybridization assay. J Clin Microbiol (1991) 1.18

Connector inversion probe technology: a powerful one-primer multiplex DNA amplification system for numerous scientific applications. PLoS One (2007) 1.18

Direct genomic fluorescent on-line sequencing and analysis using in vitro amplification of DNA. Nucleic Acids Res (1989) 1.17

Spectrum of small mutations in the dystrophin coding region. Am J Hum Genet (1995) 1.15

Identification of deletions and duplications of the DMD gene in affected males and carrier females by multiple ligation probe amplification (MLPA). Hum Genet (2005) 1.15

Nonradioactive assay for new microsatellite polymorphisms at the 5' end of the dystrophin gene, and estimation of intragenic recombination. Am J Hum Genet (1991) 1.13

Improved molecular diagnostics for ornithine transcarbamylase deficiency. Am J Hum Genet (1991) 1.12

Muscular Dystrophy Surveillance Tracking and Research Network (MD STARnet): case definition in surveillance for childhood-onset Duchenne/Becker muscular dystrophy. J Child Neurol (2010) 1.12

Emerging drugs for Duchenne muscular dystrophy. Expert Opin Emerg Drugs (2012) 1.11

The polyproline site in hinge 2 influences the functional capacity of truncated dystrophins. PLoS Genet (2010) 1.08

Improved diagnosis of Duchenne/Becker muscular dystrophy. J Clin Invest (1990) 1.08

PathogenMip assay: a multiplex pathogen detection assay. PLoS One (2007) 1.06

A novel Alu-like element rearranged in the dystrophin gene causes a splicing mutation in a family with X-linked dilated cardiomyopathy. Am J Hum Genet (1998) 1.06

The trophoblastic epithelial barrier is not infected in full-term placentae of human immunodeficiency virus-seropositive mothers undergoing antiretroviral therapy. J Virol (1999) 1.02

Congenital hydrocephalus secondary to Walker-Warburg syndrome identified on the Manitoba Neonatal Screening Programme for Duchenne muscular dystrophy. J Med Genet (1992) 1.00

Detection of the pathogenic parasite Toxoplasma gondii by specific amplification of ribosomal sequences using comultiplex polymerase chain reaction. J Clin Microbiol (1993) 1.00

Identification of transcripts from a subtraction library which might be responsible for the mild phenotype in an intrafamilially variable course of Duchenne muscular dystrophy. Hum Genet (2003) 1.00

Diagnosis and cell-based therapy for Duchenne muscular dystrophy in humans, mice, and zebrafish. J Hum Genet (2006) 0.98

Emerging technologies for the clinical microbiology laboratory. Clin Microbiol Rev (2014) 0.98

Universal primer quantitative fluorescent multiplex (UPQFM) PCR: a method to detect major and minor rearrangements of the low density lipoprotein receptor gene. J Med Genet (2000) 0.98

Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 1. Trends across the clinical groups. J Med Genet (1993) 0.96

MPrime: efficient large scale multiple primer and oligonucleotide design for customized gene microarrays. BMC Bioinformatics (2005) 0.96

Immunohistochemical analysis of dystrophin-associated proteins in Becker/Duchenne muscular dystrophy with huge in-frame deletions in the NH2-terminal and rod domains of dystrophin. J Clin Invest (1994) 0.96

Identification and characterization of new human medium reiteration frequency repeats. Nucleic Acids Res (1993) 0.95

Targeted next-generation sequencing as a comprehensive test for patients with and female carriers of DMD/BMD: a multi-population diagnostic study. Eur J Hum Genet (2013) 0.94

The current source of human Alu retroposons is a conserved gene shared with Old World monkey. Proc Natl Acad Sci U S A (1989) 0.92

DNA amplification of a further exon of Duchenne muscular dystrophy locus increase possibilities for deletion screening. Nucleic Acids Res (1989) 0.92

Multiplex co-amplification of 24 retinoblastoma gene exons after pre-amplification by long-distance PCR. Nucleic Acids Res (1996) 0.91

Splicing analysis disclosed a determinant single nucleotide for exon skipping caused by a novel intraexonic four-nucleotide deletion in the dystrophin gene. J Med Genet (2006) 0.91

Red-green color vision impairment in Duchenne muscular dystrophy. Am J Hum Genet (2007) 0.91

Analysis of quantitative PCR for the diagnosis of deletion and duplication carriers in the dystrophin gene. J Med Genet (1992) 0.90

Becker muscular dystrophy patient with a large intragenic dystrophin deletion: implications for functional minigenes and gene therapy. J Med Genet (1991) 0.90

A TaqI map of the dystrophin gene useful for deletion and carrier status analysis. J Med Genet (1992) 0.89

DNA microarrays with stem-loop DNA probes: preparation and applications. Nucleic Acids Res (2001) 0.89

Analysis of Dystrophin Gene Deletions by Multiplex PCR in Moroccan Patients. J Biomed Biotechnol (2002) 0.87

The use of a new multiplex PCR assay significantly improves the rapid detection of deletions in the dystrophin gene. Am J Hum Genet (1991) 0.86

Three cases of manifesting female carriers in patients with Duchenne muscular dystrophy. Yonsei Med J (2011) 0.86

Deletion mapping of Aland Island eye disease to Xp21 between DXS67 (B24) and Duchenne muscular dystrophy. Am J Hum Genet (1990) 0.86

Evidence of Insulin Resistance and Other Metabolic Alterations in Boys with Duchenne or Becker Muscular Dystrophy. Int J Endocrinol (2015) 0.85

Molecular analysis of recombination in a family with Duchenne muscular dystrophy and a large pericentric X chromosome inversion. Am J Hum Genet (1996) 0.85

Molecular Techniques for the Detection and Differentiation of Host and Parasitoid Species and the Implications for Fruit Fly Management. Insects (2012) 0.84

Rapid differentiation and in situ detection of 16 sourdough lactobacillus species by multiplex PCR. Appl Environ Microbiol (2005) 0.83

Relevance of sequence and structure elements for deletion events in the dystrophin gene major hot-spot. Hum Genet (2002) 0.83

Molecular diagnosis of duchenne muscular dystrophy: past, present and future in relation to implementing therapies. Clin Biochem Rev (2011) 0.83

Detection limit of intragenic deletions with targeted array comparative genomic hybridization. BMC Genet (2013) 0.83

The identification of point mutations in Duchenne muscular dystrophy patients by using reverse-transcription PCR and the protein truncation test. Am J Hum Genet (1995) 0.83

Uniparental disomy of the entire X chromosome in a female with Duchenne muscular dystrophy. Am J Hum Genet (1997) 0.83

Development of a dual-aptamer-based multiplex protein biosensor. Biosens Bioelectron (2010) 0.82

DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54

Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science (1988) 220.77

Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. Gene (1985) 213.67

Analysis of enzymatically amplified beta-globin and HLA-DQ alpha DNA with allele-specific oligonucleotide probes. Nature (1986) 17.77

Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell (1987) 16.01

An improved method for prenatal diagnosis of genetic diseases by analysis of amplified DNA sequences. Application to hemophilia A. N Engl J Med (1987) 14.37

Polymer support oligonucleotide synthesis XVIII: use of beta-cyanoethyl-N,N-dialkylamino-/N-morpholino phosphoramidite of deoxynucleosides for the synthesis of DNA fragments simplifying deprotection and isolation of the final product. Nucleic Acids Res (1984) 12.11

The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein. Cell (1988) 10.75

Detection of human papilloma virus in paraffin-embedded tissue using the polymerase chain reaction. J Exp Med (1988) 9.10

Characterization of beta-thalassaemia mutations using direct genomic sequencing of amplified single copy DNA. Nature (1987) 8.58

Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene. Nature (1986) 6.45

Cloning of the breakpoint of an X;21 translocation associated with Duchenne muscular dystrophy. Nature (1986) 3.62

A deletion hot spot in the Duchenne muscular dystrophy gene. Genomics (1988) 3.18

Disease diagnosis by recombinant DNA methods. Science (1987) 3.06

Molecular analysis of the Duchenne muscular dystrophy region using pulsed field gel electrophoresis. Cell (1987) 2.83

Further studies of gene deletions that cause Duchenne and Becker muscular dystrophies. Genomics (1988) 2.74

Screening for phenylketonuria mutations by DNA amplification with the polymerase chain reaction. Lancet (1988) 2.67

Germline mosaicism and Duchenne muscular dystrophy mutations. Nature (1987) 2.56

Transcriptional regulation of the muscle creatine kinase gene and regulated expression in transfected mouse myoblasts. Mol Cell Biol (1986) 2.47

Direct detection of more than 50% of the Duchenne muscular dystrophy mutations by field inversion gels. Nature (1987) 2.44

A physical map of 4 million bp around the Duchenne muscular dystrophy gene on the human X-chromosome. Cell (1986) 2.12

A partial deletion of the muscular dystrophy gene transmitted twice by an unaffected male. Nature (1987) 2.10

Cloning and expression of steroid sulfatase cDNA and the frequent occurrence of deletions in STS deficiency: implications for X-Y interchange. Cell (1987) 1.99

Long-range genomic map of the Duchenne muscular dystrophy (DMD) gene: isolation and use of J66 (DXS268), a distal intragenic marker. Genomics (1987) 1.89

Direct method for prenatal diagnosis and carrier detection in Duchenne/Becker muscular dystrophy using the entire dystrophin cDNA. Am J Med Genet (1988) 1.80

A 230kb cosmid walk in the Duchenne muscular dystrophy gene: detection of a conserved sequence and of a possible deletion prone region. Nucleic Acids Res (1987) 1.72

Expression of the murine Duchenne muscular dystrophy gene in muscle and brain. Science (1988) 1.70

The molecular genetics of Duchenne muscular dystrophy: the beginning of the end? Trends Genet (1988) 1.55

Prenatal testing for Duchenne and Becker muscular dystrophy. Lancet (1988) 1.54

Lambda phage vectors--EMBL series. Methods Enzymol (1987) 1.28

Molecular basis of human growth hormone gene deletions. Proc Natl Acad Sci U S A (1988) 1.24

Carrier diagnosis of Duchenne muscular dystrophy using restriction fragment length polymorphisms. Neurology (1986) 1.16

Toward a molecular understanding of ornithine transcarbamylase deficiency. Adv Neurol (1988) 1.13

Initial sequencing and analysis of the human genome. Nature (2001) 212.86

The genome sequence of Drosophila melanogaster. Science (2000) 74.32

DNA diagnostics--molecular techniques and automation. Science (1988) 8.85

Alu polymerase chain reaction: a method for rapid isolation of human-specific sequences from complex DNA sources. Proc Natl Acad Sci U S A (1989) 8.68

Absence of expression of the FMR-1 gene in fragile X syndrome. Cell (1991) 7.04

Structure, expression, and mutation of the hypoxanthine phosphoribosyltransferase gene. Proc Natl Acad Sci U S A (1984) 6.48

Genetic variation at five trimeric and tetrameric tandem repeat loci in four human population groups. Genomics (1992) 6.40

DNA typing and genetic mapping with trimeric and tetrameric tandem repeats. Am J Hum Genet (1991) 6.20

Automated DNA sequencing of the human HPRT locus. Genomics (1990) 5.92

Generation of cDNA probes directed by amino acid sequence: cloning of urate oxidase. Science (1988) 5.72

Construction of plasmids that express E. coli beta-galactosidase in mammalian cells. Nucleic Acids Res (1989) 5.02

Identification of the gene responsible for Best macular dystrophy. Nat Genet (1998) 4.89

Isolation of a Miller-Dieker lissencephaly gene containing G protein beta-subunit-like repeats. Nature (1993) 4.87

Large-scale comparative sequence analysis of the human and murine Bruton's tyrosine kinase loci reveals conserved regulatory domains. Genome Res (1997) 4.82

Identification of a (CUG)n triplet repeat RNA-binding protein and its expression in myotonic dystrophy. Nucleic Acids Res (1996) 4.75

DNA methylation represses FMR-1 transcription in fragile X syndrome. Hum Mol Genet (1992) 4.22

Analysis of deletions in DNA from patients with Becker and Duchenne muscular dystrophy. Nature (1986) 4.13

Bacterial peptide chain release factors: conserved primary structure and possible frameshift regulation of release factor 2. Proc Natl Acad Sci U S A (1985) 3.94

Comparative sequence analysis of a gene-rich cluster at human chromosome 12p13 and its syntenic region in mouse chromosome 6. Genome Res (1998) 3.80

Expression of peptide chain release factor 2 requires high-efficiency frameshift. Nature (1986) 3.60

Characterization of the human cysteinyl leukotriene CysLT1 receptor. Nature (1999) 3.57

A BAC-based physical map of the major autosomes of Drosophila melanogaster. Science (2000) 3.51

A recombination hotspot responsible for two inherited peripheral neuropathies is located near a mariner transposon-like element. Nat Genet (1996) 3.45

The American Society of Human Genetics statement on cystic fibrosis screening. Am J Hum Genet (1990) 3.07

Disease diagnosis by recombinant DNA methods. Science (1987) 3.06

Hypoxanthine-guanine phosphoribosyltransferase genes of mouse and Chinese hamster: construction and sequence analysis of cDNA recombinants. Nucleic Acids Res (1982) 3.00

Identification of mutations leading to the Lesch-Nyhan syndrome by automated direct DNA sequencing of in vitro amplified cDNA. Proc Natl Acad Sci U S A (1989) 2.97

Multiplex DNA deletion detection and exon sequencing of the hypoxanthine phosphoribosyltransferase gene in Lesch-Nyhan families. Genomics (1990) 2.84

Organization of the HPRT gene and related sequences in the human genome. Somat Cell Mol Genet (1984) 2.84

Histochemical staining of clonal mammalian cell lines expressing E. coli beta galactosidase indicates heterogeneous expression of the bacterial gene. Somat Cell Mol Genet (1987) 2.77

Decreased expression of myotonin-protein kinase messenger RNA and protein in adult form of myotonic dystrophy. Science (1993) 2.75

Analysis of the quality and utility of random shotgun sequencing at low redundancies. Genome Res (1998) 2.74

A three-allele restriction-fragment-length polymorphism at the hypoxanthine phosphoribosyltransferase locus in man. Proc Natl Acad Sci U S A (1983) 2.73

8-Azaguanine resistance in mammalian cells. I. Hypoxanthine-guanine phosphoribosyltransferase. Genetics (1972) 2.71

Cloned cDNA sequences of the hypoxanthine/guanine phosphoribosyltransferase gene from a mouse neuroblastoma cell line found to have amplified genomic sequences. Proc Natl Acad Sci U S A (1982) 2.62

A new adenoviral vector: Replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and beta-galactosidase. Proc Natl Acad Sci U S A (1996) 2.52

The HPRT locus. Cell (1979) 2.49

Multiplex PCR: advantages, development, and applications. PCR Methods Appl (1994) 2.42

Two independent mutational events in the loss of urate oxidase during hominoid evolution. J Mol Evol (1992) 2.35

PCR test for cystic fibrosis deletion. Nature (1990) 2.26

Novel proteins with binding specificity for DNA CTG repeats and RNA CUG repeats: implications for myotonic dystrophy. Hum Mol Genet (1996) 2.23

Sequential translation of trinucleotide codons for the initiation and termination of protein synthesis. Science (1968) 2.20

Large-scale concatenation cDNA sequencing. Genome Res (1997) 2.18

Long HIV-1 incubation periods and dynamics of transmission within a family. Lancet (1990) 2.17

An economic evaluation of a genetic screening program for Tay-Sachs disease. Am J Hum Genet (1978) 2.17

Large-scale sequencing in human chromosome 12p13: experimental and computational gene structure determination. Genome Res (1997) 2.17

Evaluation of 13 short tandem repeat loci for use in personal identification applications. Am J Hum Genet (1994) 2.15

Detection of single DNA base differences by competitive oligonucleotide priming. Nucleic Acids Res (1989) 2.14

Absence of messenger RNA and gene DNA for beta-globin chains in hereditary persistence of fetal hemoglobin. Cell (1976) 2.10

Deletion and amplification of the HGPRT locus in Chinese hamster cells. Mol Cell Biol (1983) 2.10

The molecular basis of the sparse fur mouse mutation. Science (1987) 2.09

Fine structure of the human hypoxanthine phosphoribosyltransferase gene. Mol Cell Biol (1986) 2.07

Molecular evidence for new mutation at the hprt locus in Lesch-Nyhan patients. Nature (1984) 2.07

Simultaneous shotgun sequencing of multiple cDNA clones. DNA Seq (1997) 2.04

The Chinese hamster HPRT gene: restriction map, sequence analysis, and multiplex PCR deletion screen. Genomics (1991) 2.03

RNA codons and protein synthesis. 15. Dissimilar responses of mammalian and bacterial transfer RNA fractions to messenger RNA codons. J Mol Biol (1968) 2.00

Fine structure of RNA codewords recognized by bacterial, amphibian, and mammalian transfer RNA. Science (1967) 1.99

Termination of DNA synthesis by novel 3'-modified-deoxyribonucleoside 5'-triphosphates. Nucleic Acids Res (1994) 1.95

Duplication of a gene-rich cluster between 16p11.1 and Xq28: a novel pericentromeric-directed mechanism for paralogous genome evolution. Hum Mol Genet (1996) 1.93

Isolation and characterization of LRP6, a novel member of the low density lipoprotein receptor gene family. Biochem Biophys Res Commun (1998) 1.93

Carrier detection and prenatal diagnosis in Duchenne and Becker muscular dystrophy families, using dinucleotide repeat polymorphisms. Am J Hum Genet (1991) 1.93

Translational frameshifting: where will it stop? Cell (1987) 1.93

DNA chips: promising toys have become powerful tools. Trends Biochem Sci (1999) 1.93

Molecular and clinical correlations of deletions leading to Duchenne and Becker muscular dystrophies. Neurology (1989) 1.88

Hyperuricemia and urate nephropathy in urate oxidase-deficient mice. Proc Natl Acad Sci U S A (1994) 1.88

Pentanucleotide repeat length polymorphism at the human CD4 locus. Nucleic Acids Res (1991) 1.85

Urate oxidase: primary structure and evolutionary implications. Proc Natl Acad Sci U S A (1989) 1.85

Peptide chain termination with mammalian release factor. Proc Natl Acad Sci U S A (1970) 1.82

A "double adaptor" method for improved shotgun library construction. Anal Biochem (1996) 1.81

In vitro translation of hypoxanthine/guanine phosphoribosyltransferase mRNA: characterization of a mouse neuroblastoma cell line that has elevated levels of hypoxanthine/guanine phosphoribosyltransferase protein. Proc Natl Acad Sci U S A (1981) 1.81

Rescue, propagation, and partial purification of a helper virus-dependent adenovirus vector. Proc Natl Acad Sci U S A (1995) 1.81

Mammalian peptide chain termination. II. Codon specificity and GTPase activity of release factor. Proc Natl Acad Sci U S A (1971) 1.79

Mutations affecting the structure of hypoxanthine: guanine phosphoribosyltransferase in cultured Chinese hamster cells. Proc Natl Acad Sci U S A (1973) 1.78

Identification and localization of mutations at the Lesch-Nyhan locus by ribonuclease A cleavage. Science (1987) 1.76

Characterization of reticulocyte release factor. J Biol Chem (1977) 1.76

An adenoviral vector deleted for all viral coding sequences results in enhanced safety and extended expression of a leptin transgene. Proc Natl Acad Sci U S A (1998) 1.76

Electrophoretically uniform fluorescent dyes for automated DNA sequencing. Science (1996) 1.75

Somatic mosaicism, germline expansions, germline reversions and intergenerational reductions in myotonic dystrophy males: small pool PCR analyses. Hum Mol Genet (1995) 1.74

HPRT: gene structure, expression, and mutation. Annu Rev Genet (1985) 1.72

Expression of the murine Duchenne muscular dystrophy gene in muscle and brain. Science (1988) 1.70

Peptide chain termination. V. The role of release factors in mRNA terminator codon recognition. Proc Natl Acad Sci U S A (1969) 1.68

Hydrolysis of fMet-tRNA by peptidyl transferase. Proc Natl Acad Sci U S A (1971) 1.67

Overexpression of M68/DcR3 in human gastrointestinal tract tumors independent of gene amplification and its location in a four-gene cluster. Proc Natl Acad Sci U S A (2000) 1.67

Altered phosphorylation and intracellular distribution of a (CUG)n triplet repeat RNA-binding protein in patients with myotonic dystrophy and in myotonin protein kinase knockout mice. Proc Natl Acad Sci U S A (1997) 1.66

Recent advances in peptide chain termination. Mol Microbiol (1990) 1.66

A gene-rich cluster between the CD4 and triosephosphate isomerase genes at human chromosome 12p13. Genome Res (1996) 1.66

Recovery of induced mutations for X chromosome-linked muscular dystrophy in mice. Proc Natl Acad Sci U S A (1989) 1.64

Optimization of the helper-dependent adenovirus system for production and potency in vivo. Proc Natl Acad Sci U S A (2000) 1.62

Somatic heterogeneity of the CTG repeat in myotonic dystrophy is age and size dependent. Am J Hum Genet (1995) 1.62